title: Brodalumab established as an effective interleukin-17 receptor antagonist in psoriasis.
authors.affiliation: University of Aberdeen, Burnside House, Cornhill Road, Aberdeen, AB25 2ZR, U.K. a.d.ormerod@abdn.ac.uk.
authors.forename: A D
authors.initials: AD
authors.lastname: Ormerod
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D020381:Interleukin-17; D011565:Psoriasis; D053722:Receptors, Interleukin-17 / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D020381:Interleukin-17; D053722:Receptors, Interleukin-17; C571216:brodalumab